Exelon Corp: Form 10-Q for the period ended Sep 30, 2012
Filed with the SEC on Nov 7, 2012 and accepted by EDGAR at Nov 7, 2012, 22:19 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2012-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2012-07-01 to 2012-09-30 | $6.57bn | us-gaap:Revenues |
| Revenue | 9 months2012-01-01 to 2012-09-30 | $17.20bn | us-gaap:Revenues |
| Operating income | 3 months2012-07-01 to 2012-09-30 | $603.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2012-01-01 to 2012-09-30 | $1.68bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2012-07-01 to 2012-09-30 | $240.0m | us-gaap:InterestExpense |
| Interest expense | 9 months2012-01-01 to 2012-09-30 | $678.0m | us-gaap:InterestExpense |
| Income tax | 3 months2012-07-01 to 2012-09-30 | $161.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2012-01-01 to 2012-09-30 | $445.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2012-07-01 to 2012-09-30 | $297.0m | us-gaap:NetIncomeLoss |
| Net income | 9 months2012-01-01 to 2012-09-30 | $787.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2012-07-01 to 2012-09-30 | $0.35 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2012-01-01 to 2012-09-30 | $0.97 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2012-07-01 to 2012-09-30 | $0.35 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2012-01-01 to 2012-09-30 | $0.97 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2012-07-01 to 2012-09-30 | 857,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2012-01-01 to 2012-09-30 | 806,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2012-01-01 to 2012-09-30 | $4.56bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2012-01-01 to 2012-09-30 | $4.14bn | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2012-01-01 to 2012-09-30 | $1.23bn | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | At period end2012-09-30 | $1.70bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2012-09-30 | $11.33bn | us-gaap:AssetsCurrent |
| Total assets | At period end2012-09-30 | $78.35bn | us-gaap:Assets |
| Current liabilities | At period end2012-09-30 | $7.77bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2012-09-30 | $56.16bn | us-gaap:Liabilities |
| Long-term debt | At period end2012-09-30 | $17.05bn | us-gaap:LongTermDebtNoncurrent |
| Short-term borrowings | At period end2012-09-30 | $60.0m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2012-09-30 | $21.82bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2012-09-30 | 854,283,102 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001193125-12-457787. Last ingested by Listed: Nov 14, 2026, 14:06 ET. Listed shows no prices and gives no investment advice.